Jiangsu Lanfeng Bio-chemical Co.,Ltd
Symbole: 002513.SZ
SHZ
4.37
CNYPrix du marché aujourd'hui
-4.9409
Ratio P/E
0.0015
Ratio PEG
1.49B
Cap MRK
- 0.00%
Rendement DIV
Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 457.3 | 24 | 84.6 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -4.9 | -4.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 532.3 | 229.2 | 299.2 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 167.8 | 98.1 | 132.7 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 43.5 | 9 | 29.6 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1575.7 | 360.3 | 546 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1526.1 | 868.2 | 935.6 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 58.6 | 43.6 | 46.9 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 58.6 | 43.6 | 46.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 8.9 | 12.3 | 9.5 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 126.8 | 96.5 | 170.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 103.6 | 94.6 | 19.8 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1823.9 | 1115.3 | 1181.9 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 3399.6 | 1475.5 | 1727.9 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 1212.9 | 543.2 | 631.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 203.3 | 108.3 | 97.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.5 | 4.8 | 1.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 408.9 | 0.1 | 0.3 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 114.1 | 6.2 | 9 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 185.8 | 333.1 | 8.3 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 631.5 | 81 | 16.1 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.5 | 0.1 | 0.3 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3148.9 | 1118 | 1061.3 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 49 | 15.3 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 373.9 | 373.9 | 340.1 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -2200 | -1867.7 | -1547 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 5.5 | -15.3 | 74.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1796.8 | 1851.4 | 1799 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 25.2 | 357.6 | 666.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3399.6 | 1475.5 | 1727.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 225.4 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 250.7 | 357.6 | 666.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 8.9 | 7.4 | 4.9 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 612.2 | 108.4 | 97.6 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 154.9 | 84.4 | 13.1 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -320.7 | -491.2 | 14.8 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 95.8 | 116.4 | 123.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 73.2 | -48.4 | -13.4 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 9.7 | 48.4 | 13.4 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 82.3 | 9.6 | 0.6 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -36.2 | 56.6 | 488.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | 18.7 | -25.5 | 11.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 26.6 | 26.8 | -486 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 73.2 | -48.4 | -13.4 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -4.6 | 377 | -11 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -31.1 | -88.9 | -107.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 7.4 | 3.7 | 258.2 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -37.6 | -10 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -7.4 | -3.7 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 58.9 | 3.7 | 70.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9.8 | -95.2 | 220.7 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | -82 | -172.1 | -364.3 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 101.5 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -101.5 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | -6 | -12.7 | -15.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 135.8 | 75.3 | 113.7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 47.8 | -109.5 | -266.3 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.3 | -1 | -6.1 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -24 | -193.8 | 76.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9 | 33 | 226.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 33 | 226.8 | 150.2 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -64.3 | 11.8 | 128.3 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -31.1 | -88.9 | -107.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -95.4 | -77.1 | 20.6 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1741.6 | 1445.2 | 1443.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1777.3 | 1435.8 | 1448.7 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | -35.7 | 9.4 | -4.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.7 | 51.8 | 72.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 182.3 | 119.3 | 168.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1959.6 | 1555.1 | 1617.4 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 1 | 7.8 | 2.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 26.5 | 13.6 | 22.6 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -136.3 | -137.1 | -7.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.7 | 51.8 | 72.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -136.3 | -137.1 | -7.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 26.5 | 13.6 | 22.6 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98.2 | 38.4 | 463.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -346.7 | -109.9 | -531.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -354.3 | -247 | -538.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -6.6 | 73.7 | -47.7 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -332.3 | -320.7 | -491.2 |
Questions fréquemment posées
Quel est le total de Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) de l'actif total?
Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) Le total des actifs est 3399589930.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est -0.026.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -2.516.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.200.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.221.
Qu'est-ce que Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -332260445.980.
Quel est l'endettement total de l'entreprise?
La dette totale est 612238812.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 182291568.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.